Literature DB >> 10507598

Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection.

C Papavassilis1, K K Mach, P A Mayser.   

Abstract

OBJECTIVE: Lipophilic Malassezia species may induce catheter-associated sepsis in newborns and immunocompromised patients receiving parenteral lipids. Therefore, we tested whether M. furfur and six other Malassezia species can use commercially available infusions as a lipid source.
DESIGN: Prospective in vitro study.
SETTING: Research laboratory in a university hospital.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: With the exception of M. restricta, all Malassezia species grow on lipid infusions. There are no substantial differences among the different brands. The most rapid growth is shown by M. furfur, which grows better on agar containing a 20% rather than a 10% lipid infusion. Growth of M. furdur and M. sympodialis can be reduced by infusions containing medium-chain triglycerides. Incubated in triglycerides, M. furfur is strongly suppressed by 50% medium-chain triglycerides and M. sympodialis by 8% medium-chain triglycerides. When medium-chain free fatty acids are added to triglycerides, both species can be suppressed by about 1% free fatty acids.
CONCLUSION: Medium-chain triglycerides and medium-chain free fatty acids are toxic for Malassezia species. Commercially available infusions containing medium-chain triglycerides might be used to prevent systemic Malassezia infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507598     DOI: 10.1097/00003246-199909000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Microbial Contamination of Neonatal Injectable Lipid Emulsions at 12 and 24 Hours' Infusion Time With Evaluation of Infection Control Measures.

Authors:  Eman A Omran; Faten F Eisa; Wafaa M K Bakr
Journal:  J Pediatr Pharmacol Ther       Date:  2020 Jan-Feb

Review 2.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff.

Authors:  Anamika Bhattacharyya; Nilu Jain; Sudhanand Prasad; Shilpi Jain; Vishal Yadav; Shamik Ghosh; Shiladitya Sengupta
Journal:  BMC Dermatol       Date:  2017-05-03

5.  Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital.

Authors:  I-Ting Chen; Chih-Cheng Chen; Hsin-Chun Huang; Kuang-Che Kuo
Journal:  Adv Neonatal Care       Date:  2020-02       Impact factor: 1.874

6.  Colonic Medium-Chain Fatty Acids Act as a Source of Energy and for Colon Maintenance but Are Not Utilized to Acylate Ghrelin.

Authors:  András Gregor; Sandra Auernigg-Haselmaier; Slave Trajanoski; Jürgen König; Kalina Duszka
Journal:  Nutrients       Date:  2021-10-26       Impact factor: 5.717

Review 7.  Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals.

Authors:  Sabri Ahmed Rial; Antony D Karelis; Karl-F Bergeron; Catherine Mounier
Journal:  Nutrients       Date:  2016-05-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.